IBD Center Conference

4th Annual Baylor University Medical Center IBD Center Conference

April 13, 2019

Baylor Charles A. Sammons Cancer Center • Dallas, Texas

About the Conference

Although great progress has been made in the treatment of the inflammatory bowel diseases, many patients feel that they are not full participants in the decision making process, others are disengaged and a few refuse therapy. This CME course will review structured, patient-specific approaches to achieve shared decision making. The course will also address approaches towards patients who have trouble accepting their diagnosis and treatment recommendations. Published and on-line resources and tools aimed at improving shared decision making, patient engagement, treatment adherence and chronic disease management will be presented. Other topics will include the role of therapeutic drug monitoring, the challenges of IBD care in the community practice, scenarios where therapy can be stopped, an update on drug safety in pregnancy, the recognition of infections in immunosuppressed patients and innovations in the treatment of perianal disease.

As a result of attending this activity, the participants should be able to:

  • Engage the patient in shared decision making
  • Employ an approach tailored to each patient
  • Enlist expertise of appropriate mental health providers
  • Identify areas where the Crohn's and Colitis Foundation can assist the practitioner in his/her role as health provider, teacher and advocate

Statement of Need

The two main Inflammatory Bowel Diseases (IBD), Crohn’s disease (CD) and ulcerative colitis (UC), are chronic, progressive idiopathic inflammatory disorders of the gastrointestinal (GI) tract. CD can affect any part of the GI tract, whereas UC affects the colon only.

A study using data from 2003-2004 estimated that approximately 436,000 Americans have CD and 512,000 have UC 1. The prevalence of CD was estimated at 151 per 100,000, while UC prevalence was estimated 178 per 100,000 1. A subsequent study using 2009 data estimated that 1,171,000 Americans have IBD (565,000 CD and 593,000 UC) 2. The protracted nature of these diseases exerts a major toll on patients in terms of need for chronic medical therapies, hospitalizations, surgery, health-related quality of life, economic productivity and social functioning. CD is responsible for $3.48 billion in total costs in the United States 3

Management of IBD is a complex, multidisciplinary process, made all the more difficult by the clinical heterogeneity of IBD and the lack of comparative effectiveness studies. Numerous studies have demonstrated practice variation, for example in the use of anti-inflammatory therapies, vaccinations and surgery. A recent study found significant variation among seven major US referral centers in the treatment of CD with immunomodulators 4. The practice variation points to areas of potential improvement in the quality of IBD care.

  1. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007 Dec;5(12):1424-9.
  2. Kappelman MD, Moore KR, Allen JK, Cook SF. Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population. Dig Dis Sci. 2013; 58(2): 519–525.
  3. Ganz ML, Sugarman R, Wang R, Hansen BB, Håkan-Bloch J. The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey. Inflamm Bowel Dis. 2016 May;22(5):1032-41.
  4. Ananthakrishnan AN, Kwon J, Raffals L, Sands B, Stenson WF, McGovern D, Kwon JH, Rheaume RL, Sandler RS. Variation in treatment of patients with inflammatory bowel diseases at major referral centers in the United States. Clin Gastroenterol Hepatol. 2015 Jun;13(6):1197-200.

Program Agenda

Presentation materials, when available, may be downloaded in pdf format.

Download all presentations

Saturday, April 13, 2019

Accreditation and Credit Designation


The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


The conference is held at the Baylor Charles A. Sammons Cancer Center on the Baylor University Medical Center at Dallas campus.

The Baylor University Medical Center campus encompasses many hospital buildings, programs and office buildings. Avariety of parking options are available, including self-park, valet, covered parking and private lots.

Download campus map

Baylor Charles A. Sammons Cancer Center
Tom Hunt Auditorium, 10th Floor
3410 Worth Street
Dallas, TX 75246


Physicians, Mid-level Providers, Other


GI Fellows


Cancellation and Refund Policy

We request that all conference attendees pre-register to assure the availability of conference materials.
No refunds will be provided for cancellations received after March 29, 2019.
Refunds (minus $25 administration fee) will be provided to registrants who cancel their registration in writing up to March 29, 2019.
The conference organizers will not be responsible for reimbursement of airline fees and other accommodation expenses.

Evaluation and Credit Claim

Evaluate the speakers and claim continuing education credit.

Contact Us

Check out all of our upcoming learning opportunities